Announcements Trials
Browse Landscape

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 201Observational 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Breast Neoplasms 9Lymphoma 3Carcinoma, Hepatocellular 3Cardiotoxicity 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sarcoma 1Recurrence 1Pseudomyxoma Peritonei 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neurotoxicity Syndromes 1Neoplasm, Residual 1Neoplasm Metastasis 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Fatigue 1Fallopian Tube Neoplasms 1Desmoid Tumors 1Colorectal Neoplasms 1Cholangiocarcinoma 1Breast Cancer Organoids 1Brain Neoplasms 1

Interventions

Gene Expression Profiling 11Surveys and Questionnaires 9Polymerase Chain Reaction 9Immunohistochemistry 9Amplified Fragment Length Polymorphism Analysis 9Flow Cytometry 8Psychiatric Rehabilitation 7Microarray Analysis 6Rituximab 5Interviews as Topic 4Cytogenetic Analysis 4Blood Specimen Collection 4Biopsy 4Therapeutics 3Immunologic Techniques 3Gene Rearrangement 3Drug Therapy 3Doxorubicin 3Data Collection 3Cyclophosphamide 3plerixafor 2Vincristine 2Prednisone 2Positron-Emission Tomography 2Phlebotomy 2Pharmacogenomic Testing 2Observation 2Neuropsychological Tests 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Lymphoma × Doxorubicin × Clear all
NCT02916316 2025-11-18

Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell

Fondazione Italiana Linfomi - ETS

Completed
127 enrolled
Lymphoid

Lymphoma, Cardiotoxicity

NCT05899621 2023-06-12

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

Ruijin Hospital

Recruiting
332 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT02486952 2016-02-22

MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma

Hoffmann-La Roche

Completed
154 enrolled 6 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡